Labcorp Holdings Inc. (NYSE: LH) has a higher price-to-earnings ratio of 46.14x compared to its average ratio, The 36-month beta value for LH is at 1.05. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 6 rating it as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for LH is 83.97M, and currently, shorts hold a 2.44% of that float. The average trading volume for LH on August 01, 2024 was 641.32K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
LH) stock’s latest price update
The stock of Labcorp Holdings Inc. (NYSE: LH) has increased by 6.07 when compared to last closing price of 215.44.Despite this, the company has seen a gain of 8.96% in its stock price over the last five trading days. zacks.com reported 2024-08-01 that Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.
LH’s Market Performance
LH’s stock has risen by 8.96% in the past week, with a monthly rise of 12.72% and a quarterly rise of 13.51%. The volatility ratio for the week is 2.37% while the volatility levels for the last 30 days are 2.26% for Labcorp Holdings Inc. The simple moving average for the last 20 days is 9.33% for LH’s stock, with a simple moving average of 8.13% for the last 200 days.
Analysts’ Opinion of LH
Many brokerage firms have already submitted their reports for LH stocks, with Argus repeating the rating for LH by listing it as a “Buy.” The predicted price for LH in the upcoming period, according to Argus is $250 based on the research report published on March 25, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see LH reach a price target of $260. The rating they have provided for LH stocks is “Outperform” according to the report published on February 26th, 2024.
Evercore ISI gave a rating of “In-line” to LH, setting the target price at $240 in the report published on February 09th of the current year.
LH Trading at 12.10% from the 50-Day Moving Average
After a stumble in the market that brought LH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.38% of loss for the given period.
Volatility was left at 2.26%, however, over the last 30 days, the volatility rate increased by 2.37%, as shares surge +11.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.84% upper at present.
During the last 5 trading sessions, LH rose by +8.33%, which changed the moving average for the period of 200-days by +12.71% in comparison to the 20-day moving average, which settled at $210.17. In addition, Labcorp Holdings Inc. saw 0.54% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LH starting from van der Vaart Sandra D, who sale 2,000 shares at the price of $210.83 back on May 14 ’24. After this action, van der Vaart Sandra D now owns 5,637 shares of Labcorp Holdings Inc., valued at $421,655 using the latest closing price.
ANDERSON KERRII B, the Director of Labcorp Holdings Inc., sale 250 shares at $200.10 during a trade that took place back on May 02 ’24, which means that ANDERSON KERRII B is holding 15,722 shares at $50,025 based on the most recent closing price.
Stock Fundamentals for LH
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.27 for the gross margin
The net margin for Labcorp Holdings Inc. stands at 0.04. The total capital return value is set at 0.09. Equity return is now at value 4.36, with 2.17 for asset returns.
Based on Labcorp Holdings Inc. (LH), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.66. The interest coverage ratio of the stock is 5.5.
Currently, EBITDA for the company is 1.7 billion with net debt to EBITDA at 3.44. When we switch over and look at the enterprise to sales, we see a ratio of 2.04. The receivables turnover for the company is 5.58for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.88.
Conclusion
In conclusion, Labcorp Holdings Inc. (LH) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
